Summary of Purpose
This is a randomized, double-blind, placebo-controlled parallel group outpatient 42-day treatment study that will utilize standard stroke rehabilitation outcome measures to evaluate the effect of DNS-3379 on upper extremity motor recovery in subjects following ischemic stroke.Read More →
The following dates are available for this trial. Trial information last updated on 29 November 2017.
|13 Nov 2017||14 Aug 2017||30 Nov 2018||30 Nov 2018||1 Nov 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Dart Neuroscience. LLC